Bitome offers noninvasive Dx tools for real-time volume status monitoring.
Bitome is a two-year-old, Boston-based connected med device company. Its first product is a noninvasive tool for monitoring hydration status with broad applications across the dialysis, diabetic, sports performance, and maternal / fetal monitoring spaces. In a first application, Bitome’s technology will precisely assess volume status in congestive heart failure (CHF) patients – a key, but hard to measure, biometric correlated with patient outcomes. In short, Bitome wants to use hydration monitoring technology to do for CHF, what glucose monitoring has done for diabetes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 6, 2020 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Mar 28, 2018 | Convertable Note | — | 1 | — | — | Detail |
Oct 17, 2016 | Convertable Note | — | 1 | — | — | Detail |
Aug 24, 2016 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
HAX | — | Convertable Note |